GONZALEZ DE REQUENA, Daniel
 Distribuzione geografica
Continente #
NA - Nord America 1.209
EU - Europa 630
AS - Asia 229
SA - Sud America 2
Totale 2.070
Nazione #
US - Stati Uniti d'America 1.204
DK - Danimarca 287
CN - Cina 120
SG - Singapore 63
SE - Svezia 57
IE - Irlanda 50
IT - Italia 50
FR - Francia 40
FI - Finlandia 36
AT - Austria 32
KR - Corea 27
DE - Germania 19
GB - Regno Unito 16
UA - Ucraina 14
NL - Olanda 8
PL - Polonia 8
BE - Belgio 5
CA - Canada 5
IN - India 5
VN - Vietnam 5
ES - Italia 4
TH - Thailandia 3
CZ - Repubblica Ceca 2
ID - Indonesia 2
PH - Filippine 2
AR - Argentina 1
CO - Colombia 1
IM - Isola di Man 1
JP - Giappone 1
SI - Slovenia 1
TW - Taiwan 1
Totale 2.070
Città #
Ann Arbor 558
Chandler 120
Beijing 86
Dublin 50
Singapore 46
Santa Clara 45
Dearborn 36
Villeurbanne 35
Vienna 32
Nyköping 29
Princeton 27
Ashburn 26
Houston 23
Medford 22
Torino 20
New York 18
Wilmington 17
Jacksonville 14
Columbus 12
Guangzhou 11
Redwood City 8
Warsaw 8
Boardman 7
Fremont 7
Milan 7
Seattle 6
Brussels 5
Fairfield 5
Munich 5
Hangzhou 4
Toronto 4
Boston 3
Jinan 3
Woodbridge 3
Amsterdam 2
Bangkok 2
Des Moines 2
Falls Church 2
Frankfurt am Main 2
Helsinki 2
Jakarta 2
London 2
Los Angeles 2
Madrid 2
Nanjing 2
Pune 2
Redmond 2
Rome 2
Verona 2
Wuhan 2
Bogotá 1
Brno 1
Buenos Aires 1
Buting 1
Chicago 1
Chongqing 1
Costa Mesa 1
Dong Ket 1
Douglas 1
Easton 1
Edinburgh 1
Florence 1
Fuzhou 1
Granollers 1
Hamburg 1
Handan 1
Kunming 1
Ljubljana 1
Manchester 1
Miami 1
Mountain View 1
Nanchang 1
Nuremberg 1
Ottawa 1
Prague 1
San Diego 1
San Jose 1
Shanghai 1
Shaoxing 1
Turin 1
Umeda 1
Vancouver 1
Villanueva De Los Infantes 1
Xian 1
Totale 1.368
Nome #
Effect of Darunavir (DRV) genotypic inhibitory quotient (gIQ) on the virological response to DRV-containing salvage regimens at 24 weeks 178
TENOFOVIR AND EMTRICITABINE CSF-TO-PLASMA RATIOS CORRELATE TO THE EXTENT OF BLOOD BRAIN-BARRIER DAMAGE 173
A pilot study evaluating plasma and intracellular pharmacokinetics (PK) of switching from atazanavir (ATV) 400mg QD to ATV 200 mg BID in HIV+ patients. 160
Determinants of Tenofovir Plasma Trough Concentrations: a Cross-sectional Analysis in the Clinical Setting 158
Pharmacokinetic Determinants of Immunovirological Response in HIV Very Late Presenters 152
Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients. 152
Tenofovir Plasma Concentrations According to Companion Drugs: a Cross-sectional Study in HIV-positive Patients with Normal Renal Function. 151
Pharmacokinetics of Raltegravir, Etravirine and Maraviroc regimen in the clinical setting 150
GREATER IMMUNOLOGICAL RECOVERY ASSOCIATED WITH ADDITIONAL ENFUVIRTIDE IN THE TREATMENT OF NAIVE HIV-INFECTED PATIENTS AT VERY ADVANCED DISEASE STAGES: 24-WEEK RESULTS OF A RANDOMIZED, CONTROLLED, PILOT STUDY 146
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens. 145
Steady-state Raltegravir Penetration in Seminal Plasma of Healthy Volunteers 141
Tipranavir (TPV) genotypic Inhibitory Quotient (gIQ) predicts virological responce at 24 weeks to TPV-based salvage regimens. 91
Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment. 86
Unexpected drug-drug interaction between tipranavir/ritonavir (TPV/RTV) and enfuvirtide (T20) 78
Evaluation of 7 different resistence interpretation algoritms and their derived gentotypic inhibitory quotients for the prediction of 48-week virological response to darunavir-based salvage regimens 71
Cut-off values of ribavirin trough concentration for sustained virological response and for hematological toxicity in HCV/HIV-co-infected patients treated with RBV and Pegylated Interferon 71
Pharmacokinetics of maraviroc administered at 150 mg QD in association with lopinavir/ritonavir as a part of a novel NRTI-sparing regimen in naïve patiens 68
Totale 2.171
Categoria #
all - tutte 5.353
article - articoli 0
book - libri 0
conference - conferenze 3.841
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020399 0 0 0 0 59 96 35 4 3 43 71 88
2020/2021197 71 1 0 13 9 7 8 3 11 10 6 58
2021/2022591 64 55 57 65 49 49 64 51 40 7 52 38
2022/2023339 30 12 10 47 28 95 16 22 38 3 21 17
2023/2024117 13 24 6 7 9 27 1 7 0 4 3 16
2024/2025148 1 7 12 23 105 0 0 0 0 0 0 0
Totale 2.171